Clinical Trial

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

Study acronym: InFoLIL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.
Trial Details
NCT Number NCT06876805
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Focal Liver Lesion
Enrollment 100 participants
Start Date 2024-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-14